Solu-Medrol

SECTION 2: Hazards identification

Appearance: White powder

Signal word

DANGER

Hazard statements

May damage the unborn child. May cause damage to blood and blood forming organs through prolonged or repeated exposure.

Additional information

Short Term: May cause eye irritation (based on components) May be harmful if absorbed through the skin. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on blood and blood forming organs. Known Clinical Effects: Adverse clinical reactions include the development of hypersensitivity and/or irritation leading to rashes, itching, and burning. Clinical use has resulted in hormonal alterations. Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. EU Indication of danger: Toxic to reproduction: Category 1 Harmful EU Hazard Symbols: EU Risk Phrases: R61 - May cause harm to the unborn child. R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.